Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
google
4
×
life sciences
4
×
national blog main
san francisco blog main
san francisco top stories
alphabet
fda
roboticsai
san francisco
startups
biological drugs
clinical trials
deals
drug delivery
drugs
gv
insulin
medical device
medical devices
mir imran
national top stories
novartis
octreotide
rani therapeutics
shire
takeda pharmaceutical
alex gorsky
american association for cancer research astrazeneca
ashley mcevoy
astrazeneca
auris health
boston blog main
boston top stories
broad institute of harvard and mit
brook byers
charles chu
crispr
crispr cas14
decheng capital
What
available
biological
biologics
can’t
cells
clears
convenience
digestive
drugs
enzymes
humans
hurdle
pill
proteins
rani’s
robotic
survive
swallowing
that’s
therapies
acquiring
auris
based
big
billion
bio
biosciences
builds
buy
cas
cash
cheaper
company’s
crispr
deal
develop
developer
diagnostics
expects
faster
Language
unset
Current search:
google
×
" life sciences "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B